The activities of the Biomathematics/Biostatistics Resource are essential for maximizing the yield of useful information from the scientific/clinical studies conducted at RPCI. An objective, quantitative approach to basic and clinical research is especially relevant when the systems under study are complex, when the numbers of experimental subjects must be kept small, when ethical concerns are critical and when program goals demand the integrated participation of several scientific groups. The overall objective of the Biomathematics/Biostatistics Resource is to assist researchers in the conduct of the scientific method: the derivation of mathematical/statistical models (hypothesis formation), experimental design, the gathering of data (database management), the fitting of models to data (dat analyses), and the simulation of data from models (making predictions). Concepts and tools from the disciplines of statistics, mathematics, engineering science and computer science are used by our group to accomplish our goals. Most projects require the use of standard math/stat tools, which are accessed via standard math/stat commercial computer software packages. However, on occasion, when some particular laboratory or clinical problem may require some innovative approach, our group will develop novel biomathematical/biostatistical concepts and methodology. If the innovative approach bears fruit, then the resource will apply the approach to more problems at Roswell, customize a software tool for routine use in specific research programs at Roswell, and then disseminate the approach to the greater scientific community. A goal of the Biomathematics/Biostatistics Resource is to act as a critical feedback element for fostering intra-programmatic, inter-programmatic and extra-programmatic creativity and productivity at Roswell Park. The Resource assists researchers to explore deeper into complex problems, and to increase the quality and objectivity of critical studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016056-26
Application #
6452242
Study Section
Project Start
2001-05-07
Project End
2003-04-30
Budget Start
Budget End
Support Year
26
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Barger, Carter J; Zhang, Wa; Sharma, Ashok et al. (2018) Expression of the POTE gene family in human ovarian cancer. Sci Rep 8:17136
Chen, George L; Carpenter, Paul A; Broady, Raewyn et al. (2018) Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease. Biol Blood Marrow Transplant 24:373-380
Eng, Kevin H; Szender, J Brian; Etter, John Lewis et al. (2018) Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study. PLoS Genet 14:e1007194
Tubbs, Anthony; Sridharan, Sriram; van Wietmarschen, Niek et al. (2018) Dual Roles of Poly(dA:dT) Tracts in Replication Initiation and Fork Collapse. Cell 174:1127-1142.e19
Bucsek, Mark J; Giridharan, Thejaswini; MacDonald, Cameron R et al. (2018) An overview of the role of sympathetic regulation of immune responses in infectious disease and autoimmunity. Int J Hyperthermia 34:135-143
Leonova, Katerina; Safina, Alfiya; Nesher, Elimelech et al. (2018) TRAIN (Transcription of Repeats Activates INterferon) in response to chromatin destabilization induced by small molecules in mammalian cells. Elife 7:
Verma, Aparajita; Rich, Laurie J; Vincent-Chong, Vui King et al. (2018) Visualizing the effects of metformin on tumor growth, vascularity, and metabolism in head and neck cancer. J Oral Pathol Med 47:484-491
Sheffer, Christine E; Miller, Austin; Bickel, Warren K et al. (2018) The treasure of now and an uncertain future: Delay discounting and health behaviors among cancer survivors. Cancer 124:4711-4719
Nesher, Elimelech; Safina, Alfiya; Aljahdali, Ieman et al. (2018) Role of Chromatin Damage and Chromatin Trapping of FACT in Mediating the Anticancer Cytotoxicity of DNA-Binding Small-Molecule Drugs. Cancer Res 78:1431-1443
Azad, T; Janse van Rensburg, H J; Lightbody, E D et al. (2018) A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis. Nat Commun 9:1061

Showing the most recent 10 out of 1555 publications